CAS: 125991-51-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | L-Glutamic acid, N-[4-[3-(2,4-diamino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)propyl]benzoyl]- REF: IN-DA000QMFCAS: 125991-51-7 | - - - | To inquire | Tue 12 Nov 24 |
 | TNP-351 REF: TM-T26283CAS: 125991-51-7 | - - - | 1,697.00 €~2,890.00 € | Tue 14 Jan 25 |
![L-Glutamic acid, N-[4-[3-(2,4-diamino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)propyl]benzoyl]-](https://static.cymitquimica.com/products/IN/thumb/DA000QMF.jpg)
L-Glutamic acid, N-[4-[3-(2,4-diamino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)propyl]benzoyl]-
CAS:125991-51-7
Formula:
C21H24N6O5
Molecular weight:
440.4525
Ref: IN-DA000QMF
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 12 Nov 2024
TNP-351
CAS:125991-51-7
Tnp 351 is a novel antifolate drug being assessed for chemotherapy of lung cancer.
Formula:
C21H24N6O5
Color and Shape:
Solid
Molecular weight:
440.45
Ref: TM-T26283
| 25mg | 1,697.00 € | ||
| 50mg | 2,219.00 € | ||
| 100mg | 2,890.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
